Physician profile
Phillip Keys
NPI 1124862024
$1,723.72
in general payments reported to CMS, 2019-2025
10 companies · $1,561 in 2025
The $1,561 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $162 · 2025: $1,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $312.70 | 2024-2025 | Tepezza, Uplizna |
| Abbvie INC. | $303.58 | 2024-2025 | |
| Carl Zeiss Meditec USA, INC. | $204.63 | 2025 | Cirrus Hd-Oct, Callisto Eye |
| Glaukos Corporation | $165.75 | 2025 | Idosetr |
| Dompe US, INC. | $149.22 | 2025 | Oxervate |
| Regeneron Pharmaceuticals, INC. | $141.08 | 2025 | Eylea Hd |
| Viiv Healthcare Company | $124.40 | 2025 | Apretude |
| Alcon Vision LLC | $118.73 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $104.87 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $98.76 | 2025 | Eylea Hd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Keys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.